Market Cap 3.92M
Revenue (ttm) 680,000.00
Net Income (ttm) -7.95M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,169.12%
Debt to Equity Ratio 0.00
Volume 43,100
Avg Vol 1,931,156
Day's Range N/A - N/A
Shares Out 1.47M
Stochastic %K 80%
Beta 3.02
Analysts Sell
Price Target $17.00

Latest News on SXTP

60 Degrees Pharmaceuticals Announces First Quarter 2025 Results

May 15, 2025, 4:31 PM EDT - 16 days ago

60 Degrees Pharmaceuticals Announces First Quarter 2025 Results


60 Degrees Pharmaceuticals, Inc. Announces 1:5 Reverse Stock Split

Feb 20, 2025, 10:36 AM EST - 3 months ago

60 Degrees Pharmaceuticals, Inc. Announces 1:5 Reverse Stock Split


60 Degrees Pharmaceuticals Announces Third Quarter 2024 Results

Nov 14, 2024, 2:31 PM EST - 7 months ago

60 Degrees Pharmaceuticals Announces Third Quarter 2024 Results


60 Degrees Pharmaceuticals Announces Second Quarter 2024 Results

Aug 14, 2024, 11:01 AM EDT - 10 months ago

60 Degrees Pharmaceuticals Announces Second Quarter 2024 Results